Financhill
Back

Apellis Pharmaceuticals Vs. Equinix Industry Stock Comparison

Sell
27

APLS
Apellis Pharmaceuticals

Last Price:
$19.21
Seasonality Move:
-16.64%
Sell
50

EQIX
Equinix

Last Price:
$764.94
Seasonality Move:
4.42%
Sell
27
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.89. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Equinix (EQIX) is a Sell

Is Equinix a Buy, Sell or Hold?

  • The current Equinix [EQIX] share price is $767.39. The Score for EQIX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EQIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

EQIX Stock Price Chart

What is Equinix's stock price today?

  • The Equinix share price today is $767.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EQIX is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 47.87 Sell
Chaikin Money Flow: 1240688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 19.08) Sell
Bollinger Bands (100): (17.15 - 24.53) Sell

EQIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 61.22 Buy
Relative Strength Index (14 RSI): 31.21 Sell
Chaikin Money Flow: -271922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (801.72 - 912.9) Sell
Bollinger Bands (100): (805.04 - 907.08) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.8 Buy
20-day SMA: 18.24 Sell
50-day SMA: 18.15 Sell
200-day SMA: 25.68 Sell
8-day EMA: 17.86 Buy
20-day EMA: 18.04 Sell
50-day EMA: 18.76 Sell
200-day EMA: 26.03 Sell

EQIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 781.02 Sell
20-day SMA: 845.56 Sell
50-day SMA: 862.8 Sell
200-day SMA: 886.23 Sell
8-day EMA: 170.53 Buy
20-day EMA: 73.08 Buy
50-day EMA: 30.09 Buy
200-day EMA: 7.64 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.74 per share.

Equinix Earnings Growth & EQIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.80 per share, an increase next quarter of $0.27 per share, an increase this year of $2.95 per share, and an increase next year of $1.72 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Equinix Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):